Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity

Journal of Experimental Medicine

Volumn 186, Issue 12, 1997, Pages 1965-1974

  Brumbaugh, Kathryn M ^a   Binstadt, Bryce A ^a   Billadeau, Daniel D ^a   Schoon, Renee A ^a   Dick, Christopher J ^a   Ten, Rosa M ^a   Leibson, Paul J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; ENZYME ACTIVATION; ENZYME ANALYSIS; GENE TRANSFER; GENETIC TRANSFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CALCIUM; ENZYME PRECURSORS; GENES, MHC CLASS I; INOSITOL PHOSPHATES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; KINETICS; MICE; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031438155     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.12.1965     Document Type: Article

References (83)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
2. Leibson, P.J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity. 6:655-661.
3. Vitale, M., S. Sivori, D. Pende, L. Moretta, and A. Moretta. 1995. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc. Natl. Acad. Sci. USA. 92:3536-3540.
4. Brunibaugh, K.M., J.J. Pérez-Villar, C.J. Dick, R.A. Schoon, M. López-Botet, and P.J. Leibson. 1996. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J. Immunol. 157:2804-2812.
5. Binstadt, B.A., K.M. Brumbaugh, C.J. Dick, A.M. Scharenberg, B.L. Williams, M. Colonna, L.L. Lanier, J.-P. Kinet, R.T. Abraham, and P.J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5:629-638.
6. Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M.C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24:2294-2298.
7. Phillips, J.H., J.E. Gumperz, P. Parham, and L.L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 268:403-405.
8. Fry, A.M., L.L. Lanier, and A. Weiss. 1996. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and tor association with protein tyrosine phosphatase 1C. J. Exp. Med. 184:295-300.
9. Bléry, M., J. Delon, A. Trautmann, A. Cambiaggi, L. Olcese, R. Biassoni, L. Moretta, P. Chavrier, A. Moretta, M. Daëron, and E. Vivier. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J. Biol. Chem. 272:8989-8996.
10. Einspahr, K.J., R.T. Abraham, B.A. Binstadt, Y. Uehara, and P.J. Leibson. 1991. Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc. Natl. Acad. Sci. USA. 88:62-69.
11. O'Shea, J.J., D.W. McVicar, D.B. Kurhns, and J.R. Ortaldo. 1992. A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J. Immunol. 148:2497-2502.
12. Vivier, E., P. Morin, C. O'Brien, B. Druker, S.F. Schlossman, and P. Anderson. 1991. Tyrosine phosphorylation of the FcγRIII(CD16): ζ complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J. Immunol. 146:206-210.
13. O'Shea, J.J., A.M. Weissman, I.C.S. Kennedy, and J.R. Ortaldo. 1991. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the ζ chain. Proc. Natl. Acad. Sci. USA. 88:350-354.
14. Ting, A.T., K.J. Einspahr, R.T. Abraham, and P.J. Leibson. 1991. Fcγ receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway. J. Immunol. 147: 3122-3127.
15. lck. Eur. J. Immunol. 25:3155-3159.
16. van Oers, N. S. C., B. Lowin-Kropf, D. Finlay, K. Connolly, and A. Weiss. 1996. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity. 5:429-436.
17. Chan, A.C., M. Iwashima, C.W. Turck, and A. Weiss. 1992. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell. 71:649-662.
18. Kolanus, W., C. Romeo, and B. Seed. 1993. T cell activation by clustered tyrosine kinases. Cell. 74:171-183.
19. Chu, D.H., H. Spits., J.-F. Peyron, R.B. Rowley, J.B. Bolen, and A. Weiss. 1996. The Syk protein tyrosine kinase can function independently of CD45 or Lck in T cell antigen receptor signaling. EMBO (Eur. Mol. Biol. Organ.) J. 15: 6251-6261.
20. Zoller, K.E., E.A. MacNeil, and J.S. Brugge. 1997. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction. J. Immunol. 158:1650-1659.
21. Elder, M.E., D. Lin, J. Clever, A.C. Chan, T.J. Hope, A. Weiss, and T.G. Parslow. 1994. Human severe combined immunodeficiency due to a detect in ZAP-70, a T cell tyrosine kinase. Science. 264:1596-1599.
22. Chan, A.C., T.A. Kadlecek, M.E. Elder, A.H. Filipovich, W.-L. Kuo, M. Iwashima, T.G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 264:1599-1601.
23. Negishi, I., N. Motoyama, K.-I. Nakayama, K. Nakayama, S. Senju, S. Hatakeyama, Q. Zhang, A.C. Chan, and D.Y. Loh. 1995. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature. 376:435-438.
24. syk kinase. Eur. J. Immunol. 24:2491-2496.
25. - B cells. J. Immunol. 158:2663-2669.
26. Gerrard, J.M., E. Hildes, E.A. Atkinson, and A.H. Greenberg. 1987. Activation of inositol cycle in large granular lymphocyte leukemia RNK following contact with an NK-sensitive tumor. Adv. Prostaglandin Thromboxane Leukotriene Res. 17:573-576.
27. Steele, T.A., and Z. Brahmi. 1988. Phosphatidylinositol metabolism accompanies early activation events in tumor target cell-stimulated human natural killer cells. Cell. Immunol. 112: 402-413.
28. Chow, S.C., J. Ng, C. Nordstedt, B.B. Fredholm, and M. Jondal. 1988. Phosphoinositide breakdown and evidence for protein kinase C involvement during human NK killing. Cell. Immunol. 114:96-103.
29. Windebank, K.P., R.T. Abraham, G. Powis, R.A. Olsen, T.J. Barna, and P.J. Leibson. 1988. Signal transduction during human natural killer cell activation: Inositol phosphate generation and regulation by cyclic AMP. J. Immunol. 141:3951-3957.
30. Stahls, A.K., and O. Carpen. 1989. Generation of inositol phosphates during triggering of cytotoxicity in human natural killer and lymphokine-activated killer cells. Scand. J. Immunol. 29:211-216.
31. Perussia, B., and G. Trinchieri. 1984. Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells J. Immunol. 132:1410-1415.
32. Ting, A.T., C.J. Dick, R.A. Schoon, L.M. Karnitz, R.T. Abraham, and P.J. Leibson. 1995. Interaction between lck and syk family tyrosine kinases in Fcγ receptor-initiated activation of natural killer cells. J. Biol. Chem. 270:16415-16421.
33. Pross, H.F., D. Callewaert, and P. Rubin. 1986. Assays for NK cell cytotoxicity - their values and pitfalls. In Immunobiology of Natural Killer Cells, Volume I. E. Lotzová and R.B. Herberman, editors. CRC Press, Inc., Boca Raton, FL. pp. 2-20.
34. Wange, R.L., R. Guitian, N. Isakov, J.D. Watts, R. Aebersold, and L.E. Samelson. 1995. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 270:18730-18733.
35. Scharenberg, A.M., S. Lin, B. Cuenod, H. Yamamura, and J.P. Kinet. 1995. Reconstitution ot interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering. EMBO (Eur. Mol. Biol. Organ. J. 14:3385-3394.
36. El-Hillal, O., T. Kurosaki, H. Yamamura, J.-P. Kinet, and A.M. Scharenberg. 1997. Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc. Natl. Acad. Sci. USA. 94:1919-1924.
37. Vivier, E., A.J. da Silva, M. Ackerly, H. Levine, C.E. Rudd, and P. Anderson. 1993. Association of a 70-kDa tyrosine phosphoprotein with the CD16:ζ:γ complex expressed in human natural killer cells. Eur. J. Immunol. 23:1872-1876.
38. Oliver, J.M., D.L. Burg, B.S. Wilson, J.L. McLaughlin, and R.L. Geahlen. 1994. Inhibition of mast cell Fc∈R1-mediated signaling and effector function by the Syk-selective inhibitor, Piceatannol J. Biol. Chem. 269:29697-29703.
39. Parham, P., editor. 1997. NK Cells. MHC Class I Antigens and Missing Self. Immunol. Rev. 155:5-221.
40. Gismondi, A., M. Milella, G. Palmieri, M. Piccoli, F. Frati, and A. Santoni. 1995. Stimulation of protein tyrosine phosphorylation by interaction of NK cells with fibronectin via α4β1 and α5β1. J. Immunol. 154:3128-3137.
41. Rabinowich, H., W.-C. Lin, M. Manciulea, R.B. Herberman, and T.L. Whiteside. 1995. Induction of protein tyrosine phosphorylation in human natural killer cells by triggering via α4β1 or α5β1 integrins. Blood. 85:1858-1864.
42. Schmidt, R.E., G. Bartley, H. Levine, S.F. Schlossman, and J. Ritz. 1985. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J. Immunol. 135:1020-1025.
43. Timonen, T., M. Patarroyo, and C.G. Gahmberg. 1988. Cd11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J. Immunol. 141:1041-1046.
44. Helander, T.S., O. Carpen, O. Turunen, P.E. Kovanen, A. Vaheri, and T. Timonen. 1996. ICAM-2 redistributed by ezrin as a target for killer cells. Nature. 382:265-268.
45. Siliciano, R.F., J.C. Pratt, R.E. Schmidt, J. Ritz, and E.L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 317:428-430.
46. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A.M. Orengo, N. Pella, R. Augagliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69 mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174:1393-1398.
47. Miyazaki, T., A. Dierich, C. Benoist, and D. Mathis. 1996. Independent modes of natural killing distinguished in mice lacking Lag3. Science. 272:405-408.
48. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G.R. Sutherland, L.L. Lanier, and J.H. Phillips. 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 4:573-581.
49. Mason, L.H., H. Yagita, and J.R. Ortaldo. 1994. LGL-1: a potential triggering molecule on murine NK cells. J. Leukocyte Biol. 55:362-370.
50. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875-884.
51. Pérez-Villar, J.J., I. Melero, A. Rodriguez, M. Carretero, J. Aramburu, S. Sivori, A.M. Orengo, A. Moretta, and M. López-Botet. 1995. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154: 5779-5788.
52. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C., Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specitic "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645-650.
53. Bottino, C., S. Sivori, M. Vitale, C. Cantoni, M. Falco, D. Pende, L. Morelli, R. Augugliaro, G. Senienzato, R. Biassoni, et al. 1996. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 26: 1816-1824.
54. Mandelboim, O., D.M. Davis, H.T. Reyburn, M. Vales-Gomez, E.G. Sheu, L. Pazmany, and J.L. Strominger. 1996. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science. 274:2097-2100.
55. Mason, L.H., S.K. Anderson, W.M. Yokoyama, H.R.C. Smith, R. Winkler-Pickett, and J.R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119-2128.
56. Carretero, M., C. Cantoni, T. Bellon, C. Bottino, R. Biassoni, A. Rodriguez, J.J. Perez-Villar, L. Moretta, A. Moretta, and M. Lopez-Botet. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur.J. Immunol. 27:563-567.
57. Houchins, J.P., L.L. Lanier, E.C. Niemi, J.H. Phillips, and J.C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:3603-3609.
58. - large granular lymphocytes. J. Exp. Med. 174:1527-1536.
59. Chambers, W.H., N.L. Vujanovic, A.B. DeLeo, M.W. Olszowy, R.B. Herberman, and J.C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lyinphokine-activated killer cells. J. Exp. Med. 169:1373-1389.
60. Giorda, R., W.A. Rudert, C. Vavassori, W.H. Chambers, J.C. Hiserodt, and M. Tnicco. 1990. NKR-P1, a signal transduction molecule on natural killer cells. Science. 249:1298-1300.
61. Ryan, J.C., E.C. Niemi, M.C. Nakamura, and W.E. Seaman. 1995. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 181:1911-1915.
62. Anderson, P., M. Caligiuri, J. Ritz, and S.F. Schlossman. 1989. CD3-negative natural killer cells express ζ TCR as part of a novel molecular complex. Science. 341:159-162.
63. Lanier, L.L., G. Yu, and J.H. Phillips. 1989. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 342:803-805.
64. Orloff, D.G., C. Ra., S.J. Frank, R.D. Klausner, and J.-P. Kinet. 1991). Family of disulphide-linked dimers containing the ζ and η chains of the T-cell receptor and the γ chain of Fc receptors. Nature. 347:189-191.
65. Kurosaki, T., I. Gander, and J.V. Ravetch. 1991. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. Proc. Natl. Acad. Sci. USA. 89:3837-3841.
66. Weiss, A., and D.R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell. 76:263-274.
67. Jouvin, M.-H., R.P. Numerof, and J.-P. Kinet. 1995. Signal transduction through the conserved motifs of the high affinity IgE receptor Fc∈RI. Sem. Immunol. 7:29-35.
68. Love, P.E., E.W. Shores, M.D. Johnson, M.L. Tremblay, E.J. Lee, A. Grinberg, S.P. Huang, A. Singer, and H. Westphal. 1993. T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science. 261:918-921.
69. Ohno, H., T. Aoe, S. Taki, D. Kitamura, Y. Ishida, K. Rajewsky, and T. Saito. 1993. Developmental and functional impairment of T cells in mice lacking CD3 zeta chains. EMBO (Eur. Mol. Biol. Organ.) J. 12:4357-4366.
70. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529.
71. Olcese, L., A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, and E. Vivier. 1997. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158:5083-5086.
72. Shiue, L., M.J. Zoller, and J.S. Brugge. 1995. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. J. Biol. Chem. 270:10498-10502.
73. syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides. Mol. Cell. Biol. 16:1471-1478.
74. LoGrasso, P.V., J. Hawkins, L.J. Frank, D. Wisniewski, and A. Marcy. 1996. Mechanism of activation for Zap-70 catalytic activity. Proc. Natl. Acad. Sci. USA. 93:12165-12170.
75. Neumeister, E.N., Y. Zhu, S. Richard, C. Terhorst, A.C. Chan, and A.S. Shaw. 1995. Binding of ZAP-70 to phosphorylated T-cell receptor ζ and η enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol. Cell. Biol. 15:3171-3178.
76. Isakov, N., R.L. Wange, J.D. Wats, R. Aebersold, and L.E. Samelson. 1996. Purification and characterization of human ZAP-70 protein-tyrosine kinase from a baculovirus expression system. J. Biol. Chem. 271:15753-15761.
77. syk by T-cell antigen receptor/CD3 stimulation. Proc. Natl. Acad. Sci. USA. 91:5301-5305.
78. syk through physical association and N-terminal tyrosine phosphorylation. Mol. Cell Biol. 14:5249-5258.
79. Latour, S., L.M.L. Chow, and A. Veillette. 1996. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J. Biol. Chem. 271:22782-22790.
80. Burshtyn, D.N., A.M. Scharenberg, N. Wagtman, S. Rajagopalan, K. Berrada, T. Yi, J.-P. Kinet, and E.O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 4:77-85.
81. Olcese, L., P. Lang, F. Vely, A. Cambiaggi, D. Marguet, M. Blery, K.L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J.C. Cambier, and E. Vivier. 1996. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156:4531-1534.
82. Campbell, K.S., M. Dessing, M. López-Botet, M. Cella, and M. Colonna. 1996. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184:93-100.
83. Valiante, N.M., J.H. Phillips, L.L. Lanier, and P. Parham. 1996. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation or a pp3d/ PLC-γ signaling complex in human natural killer (NK) cells. J. Exp. Med. 184:2243-2250.